Morgan Stanley’s Vendome Acquisition Corp I VNME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$560 Sell
55
-19
-26% -$193 ﹤0.01% 7627
2026
Q1
$746 Buy
74
+21
+40% +$212 ﹤0.01% 7513
2025
Q4
$532 Buy
+53
New +$531 ﹤0.01% 7497

Other funds holding VNME

Morgan Stanley's VNME Position: Q2 2026 in Review

Morgan Stanley reduced its Vendome Acquisition Corp I (VNME) stake by 26% in Q2 2026, selling an estimated $193 and leaving 55 shares worth $560. The position accounts for ﹤0.01% of the portfolio, ranked #7627.

Morgan Stanley first reported a position in VNME in Q4 2025 and has held it in 3 quarters since. The position peaked at $746 in Q1 2026. 42 funds tracked by Wall St. Rank hold VNME as of Q2 2026.

  • Morgan Stanley held 55 shares of Vendome Acquisition Corp I worth $560 as of Q2 2026.
  • Morgan Stanley sold 19 Vendome Acquisition Corp I shares in Q2 2026, an estimated $193.
  • Vendome Acquisition Corp I made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7627 holding.
  • Morgan Stanley first reported a position in Vendome Acquisition Corp I in Q4 2025 and has held it in 3 quarters since.
  • Morgan Stanley's Vendome Acquisition Corp I position peaked at $746 in Q1 2026.
  • 42 funds tracked by Wall St. Rank held Vendome Acquisition Corp I as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.